VTCRI leads effort to develop test for mTBI with industry partners, University of Virginia
Scientists at two of Virginia’s largest universities, working with clinicians from the two major health systems and a growing Virginia-based biotechnology company, have teamed up to address an important medical challenge — how do you accurately diagnose a mild traumatic brain injury that has subtle or no physical signs but can cause long-term damage?
Keep calm and carry on: VTCRI scientists make first serotonin measurements in humans
Scientists at the Virginia Tech Carilion Research Institute have begun to unravel how serotonin acts, based on data collected in a first-of-its-kind experiment that utilized electrochemical probes implanted into the brain of awake human beings.
VTCRI researchers join forces to improve life for children with genetic disorder
Accomplishments of three girls who received intensive therapy at the VTCRI Neuromotor Research Clinic based on innovative pediatric neurorehabilitation research have been documented in a report published in BMC Research Notes.
Scientists gain insight into the earliest changes that impair motor function during aging
A team of biomedical scientists led by Gregorio Valdez, an assistant professor at the Virginia Tech Carilion Research Institute, has found that the motor neurons responsible for controlling muscle movement do not age. Rather, it’s the synaptic inputs connected to the motor neurons that age and cause bodily decay.
VTCRI scientist awarded $2 million National Cancer Institute grant to study breast cancer
The National Cancer Institute of the National Institutes of Health has award Deborah Kelly, an associate professor at the Virginia Tech Carilion Research Institute, $2 million to study the mutated form of the breast cancer susceptibility protein (BRCA1) that is implicated in hereditary breast cancer.
Virginia Tech Carilion Research Institute scientists seek unfiltered truth about 'light' cigarettes
Scientists from multiple institutions, including a group of addiction neuroscience researchers from the Virginia Tech Carilion Research Institute, are gathering evidence under funding from the National Institutes of Health's National Cancer Institute to potentially inform a U.S. Food and Drug Administration (FDA) decision about whether to recommend design changes to filtered cigarettes.
Virginia Tech Carilion Research Institute partners with INSIGHTEC to research focused ultrasound technology
Researchers at the Virginia Tech Carilion Research Institute (VTCRI) are partnering with INSIGHTEC to develop noninvasive treatments for brain disorders using Exablate Neuro focused ultrasound and Siemens MR imaging. Through this collaboration, the institute became INSIGHTEC's first nonclinical research site.
Scientists identify new target for developing precision treatment in malignant brain tumors
A Virginia Tech Carilion Research Institute team has identified a new therapeutic target to treat glioblastoma, the most devastating and common form of brain cancer.
Scientists find heightened attention to surprise in veterans with PTSD
Scientists at the Virginia Tech Carilion Research Institute (VTCRI) have found that people with PTSD have an increased learning response to surprising events. While most everyone reacts to surprise, people with PTSD tend to pay even more attention to the unexpected.
From the Executive Director
The Virginia Tech Carilion Research Institute makes transformative scientific advances in understanding and addressing the fundamental processes of human health and disease; trains the next generation of leading biomedical scientists; facilitates discovery-based medical education; and continues to strengthen the Virginia Tech Carilion partnership as one of the nation’s premier biomedical research collaborations, based in Roanoke, Virginia.
- Read Montague invited to give talk for neuroscience seminar series at the University of Cambridge
- Scientists’ work featured on the cover of Microscopy & Analysis
- Steven Poelzing named OVPRI scholar
- Pearl Chiu featured on “With Good Reason” radio show
- Healio (May 21): Nelarabine shows ‘best ever survival data’ for children, young adults with T-cell ALL
- WDBJ-7 (May 18): Virginia Tech Carilion School of Medicine creates "Roanoke Hokie, MD" HokieBird
- American Journal of Managed Care (May 18): Study Reports Highest Survival Rates for Children, Young Adults With Certain T-Cell Leukemias
- VTCRI Addiction Recovery Research Center
- VTCRI Center for Developmental and Translational Neurobiology
- VTCRI Center for Heart and Regenerative Medicine Research
- VTCRI Center for Transformative Research in Health Behaviors
- VTCRI Computational Psychiatry Unit
- VTCRI Human Neuroimaging Laboratory
- VTCRI Neuromotor Research Clinic
- VTCRI Glial Biology in Health, Disease, and Cancer Center